In recent campaign news–just last Friday the well-respected Institute of Medicine released their report on the FDA’s inability to ensure the safety of medications on the market. The report claims that the FDA cannot address serious drug safety issues because of the lack of clear regulatory authority, chronic underfunding, and persistent organizational problems. The report recommends that Congress pass legislation that gives the FDA more authority over drug companies, especially when it comes to requiring them to do follow-up safety studies on drugs.

Go ahead and check out other posts on the Daily Dose and of course, feel free to comment! We would love to hear from you! Also, take a look on our discussion group, a place for all of us to exchange ideas on how we can work together to reform the prescription drug marketplace.